Monash University researchers have developed a new technique to boost the effectiveness of both traditional and mRNA-based vaccines in animal ...

Shares of Moderna Inc. MRNA slipped 3.43% to $65.69 Friday, on what proved to be an all-around mixed trading session for the ...

20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have ...

Warning: COVID Vaccines Linked to Cancer Risks, Experts Say** In a shocking revelation that could alter the narrative surrounding COVID-19 vaccinations, a prominent molecular vi ...

We are stronger when we are all protected against respiratory diseases,” said Dr. Tomas Aragon, public health officer for ...

A groundbreaking discovery by Victorian scientists could pave the way for stronger Covid vaccines, that better protect ...

Health Canada has approved an updated Novavax COVID-19 vaccine to protect against the variants of the virus currently ...

RNA interference (RNAi) technology has gradually become a cutting-edge technology for treating diseases such as genetic ...

THE LAWSUIT: A class action securities lawsuit was filed against Moderna, Inc. that seeks to recover losses of shareholders who were adversely affected by alleged securities fraud between January 18, ...

Pfizer Inc (NYSE: PFE) presented positive trial data for experimental drug designed for patients suffering from cancer ...

Upon authorization by the European Commission, the Omicron KP.2-adapted COVID-19 vaccine will be available for individuals 6 months of age and ...

Merck ’s MRK stock has declined around 10.3% in the past three months, losing almost $32 billion of its market value.